First Time Loading...

BioXcel Therapeutics Inc
NASDAQ:BTAI

Watchlist Manager
BioXcel Therapeutics Inc Logo
BioXcel Therapeutics Inc
NASDAQ:BTAI
Watchlist
Price: 2.17 USD -0.69%
Updated: May 14, 2024

Balance Sheet

Balance Sheet Decomposition
BioXcel Therapeutics Inc

Current Assets 72.1m
Cash & Short-Term Investments 65.2m
Receivables 71k
Other Current Assets 6.9m
Non-Current Assets 1.6m
PP&E 1.5m
Other Non-Current Assets 87k
Current Liabilities 27.3m
Accounts Payable 13.7m
Accrued Liabilities 13.4m
Other Current Liabilities 223k
Non-Current Liabilities 102.9m
Long-Term Debt 100.6m
Other Non-Current Liabilities 2.3m

Balance Sheet
BioXcel Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
0
0
1
43
32
213
233
194
65
Cash Equivalents
0
0
1
43
32
213
233
194
65
Total Receivables
0
0
0
0
0
0
0
0
0
Accounts Receivables
0
0
0
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
2
2
Other Current Assets
0
0
0
1
2
4
4
7
5
Total Current Assets
0
0
1
43
34
217
237
203
72
PP&E Net
0
0
0
0
2
3
3
2
1
PP&E Gross
0
0
0
0
2
3
3
2
1
Accumulated Depreciation
0
0
0
0
0
0
1
1
1
Other Long-Term Assets
0
0
1
0
0
0
0
1
0
Total Assets
0
N/A
0
N/A
1
N/A
44
+3 007%
36
-16%
220
+504%
239
+9%
206
-14%
74
-64%
Liabilities
Accounts Payable
0
0
0
2
5
4
5
10
14
Accrued Liabilities
0
0
1
3
3
7
12
22
13
Short-Term Debt
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
1
0
0
1
1
1
0
Total Current Liabilities
0
0
2
5
9
12
17
33
27
Long-Term Debt
0
0
0
0
0
0
0
93
101
Other Liabilities
0
0
0
0
1
1
1
3
2
Total Liabilities
0
N/A
0
+50%
2
+667%
5
+104%
10
+102%
13
+39%
18
+35%
129
+625%
130
+1%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
Retained Earnings
0
0
5
24
57
139
246
412
591
Additional Paid In Capital
0
0
4
63
84
346
467
488
534
Other Equity
0
0
0
0
0
0
0
0
0
Total Equity
0
N/A
0
-50%
1
-233%
39
N/A
27
-31%
207
+668%
222
+7%
77
-65%
57
N/A
Total Liabilities & Equity
0
N/A
0
N/A
1
N/A
44
+3 007%
36
-16%
220
+504%
239
+9%
206
-14%
74
-64%
Shares Outstanding
Common Shares Outstanding
16
16
16
16
18
24
28
28
30

See Also

Discover More